1
|
Talebi AS, Bodaghi R, Bagherzadeh S. Lifetime attributable risks (LARs) of cancer in the fetus associated with maternal radiography examinations. Int J Radiat Biol 2024; 100:420-426. [PMID: 38193807 DOI: 10.1080/09553002.2023.2295294] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2023] [Accepted: 10/14/2023] [Indexed: 01/10/2024]
Abstract
PURPOSE For various reasons, pregnant women are occasionally exposed to ionizing radiation during radiology examinations. In these situations, it is essential to determine the radiation dose to the fetus and any associated risks. The present study attempts to calculate the mean dose for the fetus to estimate the possible cancer induction and cancer mortality risks resulting from maternal radiography exams. MATERIAL AND METHODS The GATE Monte Carlo platform and a standard voxelized pregnant phantom were employed to calculate fetal radiation dose during maternal radiography exams. The data published in Biological Effects of Ionizing Radiation VII were used to convert fetal dose to lifetime attributable risks (LARs) of cancer incidence and cancer-related mortality. RESULTS The fetal doses and LARs of cancer incidence and cancer-related mortality for the radiographs of the chest and skull were negligible. The maximum LAR values for the lateral view of the abdomen in computed and digital radiography are 5598.29 and 2238.95 per 100,000 individuals, respectively. The computed radiography of the lateral view of the abdomen revealed the highest LAR of cancer-related mortality (2074.30 deaths for every 100,000 people). CONCLUSION The radiation dose incurred by the fetus due to chest and skull radiographs was minimal and unlikely to cause any abnormalities in the fetus. The discernible elevation in the lifetime attributable risk associated with cancer incidence and mortality arising from lateral computed radiography examinations of the abdomen warrants careful consideration within the realm of maternal radiography examinations.
Collapse
Affiliation(s)
- Asra Sadat Talebi
- Department of Medical Physics, Tarbiat Modares University, Tehran, Iran
| | - Roghiyeh Bodaghi
- Department of Medical Physics, Tarbiat Modares University, Tehran, Iran
| | - Saeed Bagherzadeh
- Department of Medical Physics, Tarbiat Modares University, Tehran, Iran
| |
Collapse
|
2
|
Qu S, Liu H, Xie T, Giger ML, Quan G, Zaidi H. Patient-specific fetal radiation dosimetry for pregnant patients undergoing abdominal and pelvic CT imaging. Med Phys 2023. [PMID: 36799714 DOI: 10.1002/mp.16304] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2022] [Revised: 01/18/2023] [Accepted: 01/31/2023] [Indexed: 02/18/2023] Open
Abstract
BACKGROUND Accurate estimation of fetal radiation dose is crucial for risk-benefit analysis of radiological imaging, while the radiation dosimetry studies based on individual pregnant patient are highly desired. PURPOSE To use Monte Carlo calculations for estimation of fetal radiation dose from abdominal and pelvic computed tomography (CT) examinations for a population of patients with a range of variations in patients' anatomy, abdominal circumference, gestational age (GA), fetal depth (FD), and fetal development. METHODS Forty-four patient-specific pregnant female models were constructed based on CT imaging data of pregnant patients, with gestational ages ranging from 8 to 35 weeks. The simulation of abdominal and pelvic helical CT examinations was performed on three validated commercial scanner systems to calculate organ-level fetal radiation dose. RESULTS The absorbed radiation dose to the fetus ranged between 0.97 and 2.24 mGy, with an average of 1.63 ± 0.33 mGy. The CTDIvol -normalized fetal dose ranged between 0.56 and 1.30, with an average of 0.94 ± 0.25. The normalized fetal organ dose showed significant correlations with gestational age, maternal abdominal circumference (MAC), and fetal depth. The use of ATCM technique increased the fetal radiation dose in some patients. CONCLUSION A technique enabling the calculation of organ-level radiation dose to the fetus was developed from models of actual anatomy representing a range of gestational age, maternal size, and fetal position. The developed maternal and fetal models provide a basis for reliable and accurate radiation dose estimation to fetal organs.
Collapse
Affiliation(s)
- Shuiyin Qu
- Institute of Radiation Medicine, Fudan University, Shanghai, China.,Department of Engineering Physics, Tsinghua University, Beijing, China
| | - Haikuan Liu
- Institute of Radiation Medicine, Fudan University, Shanghai, China
| | - Tianwu Xie
- Institute of Radiation Medicine, Fudan University, Shanghai, China.,Division of Nuclear Medicine and Molecular Imaging, Geneva University Hospital, Geneva, Switzerland
| | - Maryellen L Giger
- University of Chicago, Department of Radiology, Committee on Medical Physics, Chicago, Illinois, USA
| | - Guotao Quan
- Shanghai United Imaging Intelligence Co., Ltd., Shanghai, China
| | - Habib Zaidi
- Division of Nuclear Medicine and Molecular Imaging, Geneva University Hospital, Geneva, Switzerland.,Geneva Neuroscience Center, Geneva University, Geneva, Switzerland.,Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.,Department of Nuclear Medicine, University of Southern Denmark, Odense, Denmark
| |
Collapse
|
3
|
Hardy AJ, Bostani M, Kim GHJ, Cagnon CH, Zankl MA, McNitt-Gray M. Evaluating Size-Specific Dose Estimate (SSDE) as an estimate of organ doses from routine CT exams derived from Monte Carlo simulations. Med Phys 2021; 48:6160-6173. [PMID: 34309040 DOI: 10.1002/mp.15128] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2021] [Revised: 06/11/2021] [Accepted: 07/09/2021] [Indexed: 11/10/2022] Open
Abstract
PURPOSE Size-specific dose estimate (SSDE) is a metric that adjusts CTDIvol to account for patient size. While not intended to be an estimate of organ dose, AAPM Report 204 notes the difference between the patient organ dose and SSDE is expected to be 10-20%. The purpose of this work was therefore to evaluate SSDE against estimates of organ dose obtained using Monte Carlo (MC) simulation techniques applied to routine exams across a wide range of patient sizes. MATERIALS AND METHODS Size-specific dose estimate was evaluated with respect to organ dose based on three routine protocols taken from Siemens scanners: (a) brain parenchyma dose in routine head exams, (b) lung and breast dose in routine chest exams, and (c) liver, kidney, and spleen dose in routine abdomen/pelvis exams. For each exam, voxelized phantom models were created from existing models or derived from clinical patient scans. For routine head exams, 15 patient models were used which consisted of 10 GSF/ICRP voxelized phantom models and five pediatric voxelized patient models created from CT image data. For all exams, the size metric used was water equivalent diameter (Dw ). For the routine chest exams, data from 161 patients were collected with a Dw range of ~16-44 cm. For the routine abdomen/pelvis exams, data from 107 patients were collected with a range of Dw from ~16 to 44 cm. Image data from these patients were segmented to generate voxelized patient models. For routine head exams, fixed tube current (FTC) was used while tube current modulation (TCM) data for body exams were extracted from raw projection data. The voxelized patient models and tube current information were used in detailed MC simulations for organ dose estimation. Organ doses from MC simulation were normalized by CTDIvol and parameterized as a function of Dw . For each patient scan, the SSDE was obtained using Dw and CTDIvol values of each scan, according to AAPM Report 220 for body scans and Report 293 for head scans. For each protocol and each patient, normalized organ doses were compared with SSDE. A one-sided tolerance limit covering 95% (P = 0.95) of the population with 95% confidence (α = 0.05) was used to assess the upper tolerance limit (TU ) between SSDE and normalized organ dose. RESULTS For head exams, the TU between SSDE and brain parenchyma dose was observed to be 12.5%. For routine chest exams, the TU between SSDE and lung and breast dose was observed to be 35.6% and 68.3%, respectively. For routine abdomen/pelvis exams, the TU between SSDE and liver, spleen, and kidney dose was observed to be 30.7%, 33.2%, and 33.0%, respectively. CONCLUSIONS The TU of 20% between SSDE and organ dose was found to be insufficient to cover 95% of the sampled population with 95% confidence for all of the organs and protocols investigated, except for brain parenchyma dose. For the routine body exams, excluding the breasts, a wider threshold difference of ~30-36% would be needed. These results are, however, specific to Siemens scanners.
Collapse
Affiliation(s)
- Anthony James Hardy
- Materials Engineering Division/Non-destructive Evaluation Group, Livermore National Laboratory, Livermore, California, USA
| | - Maryam Bostani
- Department of Radiological Sciences, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, Livermore, USA.,Physics and Biology in Medicine Graduate Program, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA
| | - Grace Hyun J Kim
- Department of Radiological Sciences, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, Livermore, USA
| | - Christopher H Cagnon
- Department of Radiological Sciences, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, Livermore, USA.,Physics and Biology in Medicine Graduate Program, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA
| | - Maria Agnes Zankl
- Institute of Radiation Medicine, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH, Neuherberg, Germany
| | - Michael McNitt-Gray
- Department of Radiological Sciences, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, Livermore, USA.,Physics and Biology in Medicine Graduate Program, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA
| |
Collapse
|
4
|
Fetal dose evaluation for body CT examinations of pregnant patients during all stages of pregnancy. Eur J Radiol 2021; 141:109780. [PMID: 34049058 DOI: 10.1016/j.ejrad.2021.109780] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2020] [Revised: 04/23/2021] [Accepted: 05/13/2021] [Indexed: 11/23/2022]
Abstract
PURPOSE CTDIvol-to-fetal-dose coefficients from Monte Carlo simulations are useful for fetal dose evaluations, but the available data is limited to the fetus being completely inside the abdominopelvic scan range. Whereas in a chest examination, the fetus is completely outside the scan range. In an abdominal examination, the fetus after 16 gestational weeks is partly in the scan region, and an earlier fetus is completely outside of it. This work proposes a practical approach to evaluate fetal dose for pregnant patients undergoing body CT examinations, without using Monte Carlo simulation. METHODS The proposed method was based on the z-axis dose profile computed for a CT examination, considering CTDIvol, scan range, mA, and maternal WED (water equivalent diameter) at the fetus centroid. Fetal average dose was calculated over the fetus z-axis coverage. For validation, we considered a reference dataset of 24 pregnant patients, each underwent two abdominopelvic examinations (fixed mA, tube current modulation). WED was 30.1 ± 3.3 (25.3-35.6) cm [mean(range)]. Gestational age was <5 weeks for one patient, and 20.3 ± 9.1 (5-35.9) weeks for the others. Fetal depth (from the anterior skin surface to the most anterior part of fetus) was 6.1 ± 2.1 (2.5-10.9) cm. We further considered three whole-body models of a pregnant patient (gestational age, 3, 6, 9 months; weight, 62-73 kg) undergoing chest, abdominal, and abdominopelvic examinations (fixed mA). For the patients and models, profile-based fetal dose calculations were compared with the results of Monte Carlo simulations. Statistical software (R, version 3.5.1) was used to determine the mean and 95th percentile. RESULTS The fetal dose difference between profile-based evaluations and Monte Carlo simulations was (5.9 ± 3.8)% for 24 fixed-mA examinations, (5.8 ± 4.6)% for 24 tube current modulated examinations, and (8.8 ± 5.9)% for the whole-body models in three scan ranges. CONCLUSIONS Profile-based fetal dose calculations can be performed for patients in body CT, considering maternal size, fetus size and location, and whether fetus is completely inside, partly inside, or outside scan ranges.
Collapse
|